Spinout Active LTD

Company profile

Obrizum Group LTD.

UK company 09685974, incorporated on 14 July 2015.

OBRIZUM | The Digital Learning Transformation Partner

Transform your corporate digital learning experience with OBRIZUM'S AI-powered adaptive learning platform.

Company number
09685974
Incorporated
14 Jul 2015
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
14 July 2015

Company number 09685974

Verify at Companies House
Legal name
OBRIZUM GROUP LTD.
Company type
Private Limited Company
Region
East of England
Registered address
SERENDIPITY LABS
1 CAMBRIDGE SQUARE
CAMBRIDGE
UNITED KINGDOM
CB4 0AE
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
45

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

27 Jul
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

28 Jul
2026

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzUzNTIzNTQwOWFkaXF6a2N4

Published 28 Jul 2026 16:27

13 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

14 Jul
2015

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

CamBioScience Limited provides intensive training courses in breakthrough life science technologies for professionals in academia and industry.

Project impact

To date the company has trained an international customer base of professional scientists from over 60 leading academic and industrial institutions and more than 30 countries worldwide. As of 2017 CamBioScience began scaling-up its capacity to deliver breakthrough course content via the construction of a bespoke cloud-based e-learning platform aimed at disrupting cutting-edge knowledge acquisition and assessment in the wider life science sectors (biotechnology, bioengineering, biopharma and medtech).

CamBioScience
2015

Public funding

2 awards
First funded
2020
Funded years
2020
Age at first award
4 years

Projects

2020 Collaborative R&D Lead participant

TRADISET: Knowledge-Trading of Digital Assets

1 Dec 2020 to 28 Feb 2022

Awarded
£296,393
Total cost £387,493

COVID-19 has resulted in a fundamental reset of relationships between businesses and its people. Only a short time ago, a typical business would spend excessive time/money on trialling different ideas, business cases and change models in order to deliver remote and agile learning. Our cloud-based enterprise learning platform (OBRIZUM), gives organisations...

2020 Collaborative R&D Lead participant

Adaptive cloud-based virtual reality for corporate training using bespoke machine learning

15 Jun 2020 to 15 Jun 2023

Awarded
£999,999
Total cost £1,386,834

E-Learning offers significant benefits over face-to-face learning, including scalability, consistency, reduced cost, and flexibility of application. However, e-Learning suffers from drawbacks including a lack of specificity to a user's learning trajectory, and the limitations of learning materials delivered through a computer monitor. The OBRIZUM Group's ...

Product types

Collaborative R&D